Vertex Pharmaceuticals (VX1) Q3 2026 Earnings Report
DE:VX1 Q3 2026 EPS Results
- Actual EPS
- EUR 2.29
- Consensus EPS
- EUR 4.31
- Beat/Miss
- Missed by -EUR 2.02
- One Year Ago EPS
- EUR 4.30
DE:VX1 Q3 2026 Revenue Results
- Actual Revenue
- EUR 3.08B
- Expected Revenue
- EUR 3.06B
- Beat/Miss
- Beat by +EUR 19.86M
- YoY Revenue Growth
- +10.44%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/02/2026
- Time
- After Close
- Conference Call
- Monday, November 2, 2026
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | ―- | 4.5 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.312.29 | 4.3 | -46.67% (-2.01) | |
| Aug 03, 2026 | 2026 (Q2) | 4.254.24 | 4.05 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.804.00 | 3.64 | 10.10% (+0.37) | |
| Feb 12, 2026 | 2025 (Q4) | 4.584.50 | 3.56 | 26.38% (+0.94) | |
| Nov 03, 2025 | 2025 (Q3) | 4.094.30 | 3.92 | 9.59% (+0.38) | |
| Aug 06, 2025 | 2025 (Q2) | 3.844.05 | -11.49 | 135.23% (+15.54) | |
| May 05, 2025 | 2025 (Q1) | 3.873.64 | 4.26 | -14.71% (-0.63) | |
| Feb 10, 2025 | 2024 (Q4) | 3.603.56 | 3.76 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.653.92 | 3.65 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
